BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 16796605)

  • 1. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular side effects of anabolic-androgenic steroids].
    Kindermann W
    Herz; 2006 Sep; 31(6):566-73. PubMed ID: 17036188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users.
    Graham MR; Baker JS; Evans P; Kicman A; Cowan D; Hullin D; Davies B
    Growth Horm IGF Res; 2007 Jun; 17(3):201-9. PubMed ID: 17324600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic elastic properties in athletes using anabolic-androgenic steroids.
    Kasikcioglu E; Oflaz H; Arslan A; Topcu B; Kasikcioglu HA; Umman B; Bugra Z; Kayserilioglu A
    Int J Cardiol; 2007 Jan; 114(1):132-4. PubMed ID: 16364476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal.
    Hartgens F; Kuipers H; Wijnen JA; Keizer HA
    Int J Sports Med; 1996 Aug; 17(6):429-33. PubMed ID: 8884417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
    de Ronde W
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of anabolic steroids and strength training on the human immune response.
    Calabrese LH; Kleiner SM; Barna BP; Skibinski CI; Kirkendall DT; Lahita RG; Lombardo JA
    Med Sci Sports Exerc; 1989 Aug; 21(4):386-92. PubMed ID: 2674590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular implications of anabolic steroid abuse.
    Cheever K; House MA
    J Cardiovasc Nurs; 1992 Jan; 6(2):19-30. PubMed ID: 1729424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
    Santos MA; Oliveira CV; Silva AS
    Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgenic anabolic steroids and arterial structure and function in male bodybuilders.
    Sader MA; Griffiths KA; McCredie RJ; Handelsman DJ; Celermajer DS
    J Am Coll Cardiol; 2001 Jan; 37(1):224-30. PubMed ID: 11153743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.
    Hurley BF; Seals DR; Hagberg JM; Goldberg AC; Ostrove SM; Holloszy JO; Wiest WG; Goldberg AP
    JAMA; 1984 Jul; 252(4):507-13. PubMed ID: 6737643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
    Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
    [No Abstract]   [Full Text] [Related]  

  • 19. Side effects of anabolic androgenic steroids abuse.
    Bonetti A; Tirelli F; Catapano A; Dazzi D; Dei Cas A; Solito F; Ceda G; Reverberi C; Monica C; Pipitone S; Elia G; Spattini M; Magnati G
    Int J Sports Med; 2008 Aug; 29(8):679-87. PubMed ID: 18004690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgenic-anabolic steroids abuse in males.
    Di Luigi L; Romanelli F; Lenzi A
    J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.